Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary Reteplase in Acute STEMI (RECOVERII)
NCT04571580Phase 3Terminated
- Start
- Jul 2021
- Primary completion
- Jan 2023
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of reteplase in ST elevation myocardial infarction (STEMI) (3 arms). Primary endpoint: Myocardial Infarct Size (% Left Ventricular Mass). Started Jul 2021; status: terminated.
02
Drugs
reteplase
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT04571580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04571580.